Abstracts

389 – CD4-Targeted Lipid Nanoparticle Delivery of Tat mRNA Induces HIV-1 Transcription in Hu-Mice on ART

Background Shock and kill HIV-1 cure strategies seek to induce proviral gene expression to permit immunological elimination of persistently infected cells under antiretroviral therapy (ART). As HIV-1 Tat potently amplifies proviral transcription, we developed CD4-targeting lipid nanoparticles (LNPs) encapsulating tat mRNA (CD4-LNP-Tat) to drive HIV-1 proviral gene expression in humanized mice (hu-mice). To enable real-time…

824 – TORCH Infections as Risk Factor for Adverse Birth Outcomes Among HIV-Exposed Neonates in Uganda

Background Prematurity and low birth weight (LBW) are leading risk factors for morbidity among HIV-exposed uninfected (HEU) neonates. The IMPAACT PROMISE 1077BF trial found high rates of adverse pregnancy outcomes among women living with HIV (WLHIV) randomized to triple antiretroviral treatment compared to zidovudine alone. We sought to elucidate the possible role of TORCH infections…

296 – Antigen-Specific Memory B Cells of Extrafollicular Origin May Contribute to ART-Free HIV Control

Background T cell-dependent antigens drive two distinct class-switched B cell responses, extrafollicular and germinal center reactions, that can both give rise to durable memory B cell populations. While an atypical B cell population, resembling transient activated B cells, has been reported in peripheral blood samples from persons living with HIV (PLWH), the functional contribution of these…

361 – Longitudinal Dynamics of Polyadenylated HIV Transcripts During Treatment Interruption

Background Individuals living with HIV require antiretroviral therapy (ART) to suppress viral replication. When therapy is stopped, most experience virologic rebound, but the interval between cessation and rebound varies widely, and the events preceding rebound are poorly understood. We examined how levels of polyadenylated (poly-A) HIV transcripts change during analytic treatment interruption (ATI), hypothesizing that…